-
Mashup Score: 4
Introduction Lupus nephritis (LN) is more prevalent in patients with SLE of Asian ethnicity than in Caucasian patients. Belimumab became available in Japan in 2017 to treat patients with SLE, including those with LN. In the BLISS-LN trial ([NCT01639339][1]), belimumab showed a favourable effect on renal outcomes when combined with standard therapy (ST) starting at the induction treatment phase…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2
Introduction Lupus nephritis (LN) is more prevalent in patients with SLE of Asian ethnicity than in Caucasian patients. Belimumab became available in Japan in 2017 to treat patients with SLE, including those with LN. In the BLISS-LN trial ([NCT01639339][1]), belimumab showed a favourable effect on renal outcomes when combined with standard therapy (ST) starting at the induction treatment phase…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Retransplants comprise approximately 5% of annual lung transplants worldwide. The factor most strongly associated with 1 year mortality in this population was the duration of time since the primary lung transplant, with a persistent reduction in risk as more time elapses.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1
Background In severe cases, SARS-CoV-2 infection leads to acute respiratory distress syndrome (ARDS), often treated by extracorporeal membrane oxygenation (ECMO). During ECMO therapy, anticoagulation is crucial to prevent device-associated thrombosis and device failure, however, it is associated with bleeding complications. In COVID-19, additional pathologies, such as endotheliitis, may further…
Source: BioMed CentralCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 2Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0
Ethical approval has been obtained for the activities involved in phase 1 from the University of Toronto’s Human Research Ethics Programme (approval number 39695). Future ethics approvals will depend on information gathered in the proceeding phase; thus, ethical approval for phase 2 and 3 of this st …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry - PubMed - 2 year(s) ago
Progression is common in patients with fibrotic ILD, and is similarly prevalent in HP and IPF. Routinely collected variables help identify patients at risk for progression and may guide therapeutic strategies.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1
Objective To determine the presence of axial symptoms in patients with psoriatic arthritis (PsA) and examine differences between those with or without a diagnosis of axial PsA (axPsA). Methods Patients with PsA at their Corevitas’ (formerly Corrona) Psoriatic Arthritis/Spondyloarthritis Registry enrollment visit were stratified into 4 mutually exclusive groups based on axial manifestations:…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data from the USIDNET Registry - 2 year(s) ago
Capsule Summary: In the USIDNET CID population, genetic diagnoses as well as infection burden impact HSCT rates, while specific genetic diagnoses and invasive viral infections carry an increased risk of mortality.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 2
Asthmatics have accelerated lung function decline over time compared with healthy individuals.
Categories: Allergy-Immunology, Latest HeadlinesTweet
Postmarketing #study & #Lupus #Registry of #Nationwide Institutions, the #MOONLIGHT study explore effectiveness of #belimumab + ST by examining risk reduction in renal flare, ability to taper #corticosteroid treatment & #systemic responsiveness 3yrs after https://t.co/YGbo8x8WEs